Top Institutions in Ophthalmology and Endocrinology
Institutions leading in this area combine expertise in diabetic eye disease, endocrinology, and clinical trials involving GLP-1 agonists. They utilize large-scale clinical trials, real-world data analysis, and advanced retinal imaging technologies to study DR progression and treatment safety.
-
#1
Joslin Diabetes Center
Boston, MA
Joslin is a world-renowned diabetes research center with extensive expertise in diabetic retinopathy and clinical trials involving novel diabetes therapies including GLP-1 agonists. They integrate endocrinology and ophthalmology research to understand diabetes complications.
Key Differentiators
- Diabetes Research
- Ophthalmology
- Endocrinology
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Mass Eye and Ear is a top ophthalmology center with specialized programs in diabetic retinopathy and advanced retinal imaging technologies, contributing to understanding the ocular effects of diabetes medications.
Key Differentiators
- Ophthalmology
- Retinal Diseases
-
#3
Mayo Clinic
Rochester, MN
Mayo Clinic has a multidisciplinary approach to diabetes and its complications, including diabetic retinopathy, with active involvement in clinical trials assessing GLP-1 agonists and their ocular safety profiles.
Key Differentiators
- Endocrinology
- Ophthalmology
- Clinical Research
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in diabetes and eye disease research, with strong programs investigating the pathophysiology of diabetic retinopathy and the effects of diabetes medications including GLP-1 agonists.
Key Differentiators
- Ophthalmology
- Endocrinology
- Diabetes Research
-
#5
University of Miami Miller School of Medicine
Miami, FL
The University of Miami has a strong focus on diabetic eye disease and endocrinology, conducting research on the impact of diabetes medications on retinal health and implementing advanced screening technologies.
Key Differentiators
- Ophthalmology
- Endocrinology
- Diabetes Complications
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


